Claudio Botti

4.7k citations
143 papers · 3.6k · h-index 33

Impact in

    • Cancer, Lipids, and Metabolism
    • Cancer, Hypoxia, and Metabolism
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

    • Cancer Treatment and Pharmacology 16
    • HER2/EGFR in Cancer Research 16
    • Cancer-related Molecular Pathways 11
    • Breast Cancer Treatment Studies 30
    • Cancer, Lipids, and Metabolism 11

Claudio Botti

134 papers receiving 3.5k citations

Peers

Claudio Botti
Comparison fields: 5 of 128
  • Cancer Research 1.4k
  • Oncology 1.3k
  • Immunology and Allergy 235
  • Molecular Biology 1.4k
  • Pathology and Forensic Medicine 348
Replace David R. Shalinsky with:
David R. Shalinsky United States
Vincent A. Memoli United States
Barbara Schmalfeldt Germany
Guoying Wang China
Robert R. Langley United States
Gilad Ben‐Baruch Israel
Susan M. Henshall Australia
Trivadi S. Ganesan India
Ryo Hosotani Japan
David Waltregny Belgium
Claudio Botti relative to David R. Shalinsky United States David R. Shalinsky's profile →
Citations per field
00.5×1.5×
David R. Shalinsky · 1×
Citations per year

Countries citing papers authored by Claudio Botti

Since Specialization
Citations

This map shows the geographic impact of Claudio Botti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Botti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Botti more than expected).

Fields of papers citing papers by Claudio Botti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Botti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Botti. The network helps show where Claudio Botti may publish in the future.

Co-authors

The 25 scholars most cited alongside Claudio Botti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claudio Botti Line = papers co-authored together Claudio Botti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1996271
2 1991129
3 1999110
4
Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.
2005107
5 1992103
6
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
200196
7 199293
8 200091
9 198789
10 201486
11 200674
12 200574
13 200072
14 200171
15 200471
16
Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
199966
17
Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinoma.
200765
18 200365
19 200061
20 199159

About Claudio Botti

Claudio Botti is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 143 papers that have together received 3.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (30 papers), Cancer Treatment and Pharmacology (16 papers), HER2/EGFR in Cancer Research (16 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Genetic factors in colorectal cancer (11 papers), Cancer, Lipids, and Metabolism (11 papers), Cancer-related Molecular Pathways (11 papers) and Lung Cancer Treatments and Mutations (10 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.3k citations), Immunology and Allergy (235 citations), Molecular Biology (1.4k citations) and Pathology and Forensic Medicine (348 citations). Claudio Botti has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Paolo Visca, Marcella Mottolese, Piero Alò, Ugo Di Tondo, Pier Giorgio Natali, Antonella Mangoni, Patrizia Vici, Diana Giannarelli, Valeria Sebastiani and Franco Di Filippo. Their work appears in journals such as The International Journal of Biological Markers, International Journal of Cancer, Cortex, Cancers and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact